FCAS
First Command Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.6K | Sell |
1,914
-631
| -25% | -$29.2K | ﹤0.01% | 241 |
|
|
2025
Q1 | $155K | Buy |
2,545
+803
| +46% | +$49K | ﹤0.01% | 187 |
|
|
2024
Q4 | $98.5K | Hold |
1,742
| – | – | ﹤0.01% | 221 |
|
|
2024
Q3 | $90.1K | Hold |
1,742
| – | – | ﹤0.01% | 239 |
|
|
2024
Q2 | $72.3K | Sell |
1,742
-288
| -14% | -$12K | ﹤0.01% | 237 |
|
|
2024
Q1 | $110K | Sell |
2,030
-15,973
| -89% | -$866K | ﹤0.01% | 194 |
|
|
2023
Q4 | $924K | Hold |
18,003
| – | – | 0.01% | 62 |
|
|
2023
Q3 | $1.04M | Buy |
+18,003
| New | +$1.04M | 0.01% | 51 |
|
|
2022
Q3 | – | Sell |
-810
| Closed | -$62K | – | 58 |
|
|
2022
Q2 | $62K | Buy |
+810
| New | +$62K | ﹤0.01% | 12 |
|
|
2020
Q4 | – | Sell |
-147
| Closed | -$9K | – | 39 |
|
|
2020
Q3 | $9K | Buy |
+147
| New | +$9K | ﹤0.01% | 21 |
|